tiprankstipranks
Trending News
More News >
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
US Market

Elicio Therapeutics (ELTX) Income Statement

Compare
223 Followers

Elicio Therapeutics Income Statement

Last quarter (Q4 2025), Elicio Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Elicio Therapeutics's net income was $-7.72M. See Elicio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 28.31M
Gross Profit
$ -1.13M$ -1.18M$ -1.17M$ -1.06M$ 27.08M
Operating Expenses
$ 36.59M$ 43.81M$ 34.58M$ 22.68M$ 66.39M
Depreciation and Amortization
$ 1.13M$ 1.18M$ 1.17M$ 1.06M$ 801.00K
EBITDA
$ -36.59M$ -50.27M$ -32.97M$ -23.55M$ -51.92M
Operating Income
$ -37.71M$ -44.99M$ -35.74M$ -23.73M$ -39.31M
Other Income/Expenses
$ -1.86M$ -6.91M$ 550.00K$ -4.47M$ -15.27M
Pretax Income
$ -39.57M$ -51.90M$ -35.20M$ -28.21M$ -54.57M
Net Income
$ -39.57M$ -51.90M$ -35.20M$ -28.21M$ -26.40M
Per Share Metrics
Basic EPS
$ -2.58$ -4.25$ -6.96$ -9.10$ -19.32
Diluted EPS
$ -2.58$ -4.25$ -6.96$ -9.10$ -19.32
Weighted Average Shares Outstanding
15.31M 12.20M 5.06M 3.10M 3.20M
Weighted Average Shares Outstanding (Diluted)
15.31M 12.20M 5.06M 3.10M 3.20M
Currency in USD

Elicio Therapeutics Earnings and Revenue History